# Co-Diagnostics, Inc. (CODX) · Edgar & Edgarette company card

> Co-Diagnostics (CODX) saw revenue fall 84.1% in FY2025 to $1 million, operating margin -8059% against a 1.2% median for surgical & medical instruments & apparatus, equity 83.4% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1692415 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/CODX) · [JSON](https://www.pops4.com/boards/company/CODX.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $622,489 |
| Revenue growth, 1 year | -84.1% |
| Revenue growth per year | -71.8% |
| Operating margin | -8058.8% (prior year -1023.7%) |
| Net margin | -7533.6% |
| Operating cash flow | −$29M |
| Capital spending | $700,047 |
| Free cash flow | −$30M |
| Cash | $12M |
| Long-term debt | — |
| Total assets | $25M |
| Total equity | $21M |
| Equity ÷ assets | 83.4% |
| Return on equity | -227.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -16.26 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Beneish M: 0.3 (above the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$29.1M in FY2025); operating loss: a margin of -8058.8% in FY2025; revenue is hard to predict: its 80% range is ±74%

## Edgarette's reading

Exposure: revenue $622K (FY2025). Experience: revenue down 84.1% on the year, down 71.8% a year over 4 years; operating margin -8058.8%, down from -1023.7%. Soundness: equity 83.4% of assets, return on equity -227.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $51K and $333K next year (method v4.1: its own 3-year record of growth weighed at 40% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $44K to $380K. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -8058.8% against a 1.2% median; growth -84.1% against 11.6%.

Range logged 2026-09-26, receipt d609e40d170f6d08, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-01-13 ([filing](https://www.sec.gov/Archives/edgar/data/1692415/000149315226001971/0001493152-26-001971-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-09-04 ([filing](https://www.sec.gov/Archives/edgar/data/1692415/000149315226041560/0001493152-26-041560-index.htm))

## Recent filings

- DEF 14A · filed 2026-10-26 · [filing](https://www.sec.gov/Archives/edgar/data/1692415/000149315226048507/0001493152-26-048507-index.htm)
- 8-K · filed 2026-10-15 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1692415/000149315226047242/0001493152-26-047242-index.htm)
- 8-K · filed 2026-10-13 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1692415/000149315226046676/0001493152-26-046676-index.htm)
- 8-K · filed 2026-10-05 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1692415/000149315226045652/0001493152-26-045652-index.htm)
- 8-K · filed 2026-09-25 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1692415/000149315226044346/0001493152-26-044346-index.htm)
- 8-K · filed 2026-09-16 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1692415/000149315226042854/0001493152-26-042854-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001692415.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1692415

## Cite

POPS4, Edgar & Edgarette: Co-Diagnostics, Inc. (CODX) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/CODX. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.